Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travel-related health risks and pre-travel vaccination efficacy in immunocompromised rheumatic patients
NL-OMON33688Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate, leflunomide, infliximab, etanercept, adalimumab and 5 more, sponsored by Leiden University Medical Center. Primary endpoints: Travel-related infectious diseases, Consequences of illness and 1 more. Started Apr 2009; status: active, not recruiting.
02
Drugs
Beyond the preview
Go deeper on NL-OMON33688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33688.